Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification.
about
Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelinghiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsInduced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningAutophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgottenMaturation status of sarcomere structure and function in human iPSC-derived cardiac myocytesRecent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian DescendantsInherited heart disease - what can we expect from the second decade of human iPS cell research?hiPSC Modeling of Inherited CardiomyopathiesModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesEngineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytesMetabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle PathologyThe Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Induced pluripotent stem cell models of lysosomal storage disorders.From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various ApplicationsInvestigating human disease using stem cell models.Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds.Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.Niemann-Pick Disease Type C: Induced Pluripotent Stem Cell-Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy.Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type ANew lessons learned from disease modeling with induced pluripotent stem cells.Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseasesTranscription factor EB (TFEB) is a new therapeutic target for Pompe diseaseWITHDRAWN: Clearance of lysosomal glycogen accumulation by Transcription factor EB (TFEB) in muscle cells from lysosomal alpha-glucosidase deficient mice.Induced pluripotent stem cells in cardiovascular drug discovery.LHX2 regulates the neural differentiation of human embryonic stem cells via transcriptional modulation of PAX6 and CER1.Human-induced pluripotent stem cell approaches to model inborn and acquired metabolic heart diseases.Mitochondrial Copy Number and D-Loop Variants in Pompe Patients.Pluripotent stem cell models of human heart diseaseMechanotransduction and Metabolism in Cardiomyocyte Microdomains.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Suppression of the SOX2 neural effector gene by PRDM1 promotes human germ cell fate in embryonic stem cells.Disease models for the development of therapies for lysosomal storage diseases.Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.Prospective in vitro models of channelopathies and cardiomyopathiesAdvances in the understanding of Barth syndrome.Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development.
P2860
Q26750618-05D968F3-A25D-4F15-9B65-87D79DA72D28Q26751506-E5091B91-236C-4C8A-9B6B-5988C58E6E8BQ26775122-75032F8B-5EA9-461E-8AE0-9690771511BFQ26781825-D6BFD485-1A49-4BC1-B2A4-1B8F926130DEQ26798131-EF01D28C-4E1E-4D0E-8D86-D63896054214Q26828408-672B1896-71D1-48A4-ACED-804098E25539Q27015911-6B265045-11F0-4D65-996F-2B6C5ED23E52Q27024992-E1103F55-6C5D-4D3E-9EDD-C0E40D9D48D8Q28075331-C4783573-F046-4D09-8CDC-1B5C5571E6C8Q28079217-9E0153CE-1E48-44F1-9E96-7F68B51B5B86Q28240320-90FF88AD-9929-4B46-AE4F-C0A110417BB8Q28255887-7ED172D6-078A-45C5-B371-EDF0DC8667FBQ30574106-8620DB28-6323-4D93-9EF4-2A8924E611BFQ33722241-470EB408-C33B-40C6-8048-BADE6AA5BE32Q33748399-53A9FB0D-2278-407A-AC7C-90D71F8FD700Q33830512-EA477BBE-BD14-4FDE-A336-4F4E18FC5711Q33847517-E0396928-666F-4555-87A0-F491DE156E27Q34431170-22ACFFF0-3A8C-4536-BC4D-7A138E672548Q34464236-5F5815C5-1C39-403F-AB0D-46C27AFDF6D9Q35604274-522D23F2-0AFA-4684-B750-07EBC7C139F6Q35765543-958D9D6A-A323-410B-AFA4-63E430B74523Q35930603-CF6917B7-FE89-4778-BBD2-46FC66965199Q36093032-A461E453-C782-4955-986C-9A718C169C5AQ36374130-61173934-6856-45E4-A04C-018437F9015AQ36633022-2DABD1B6-97D1-4C6F-BE92-C969034A3583Q36870093-8103005E-2022-43B2-8A24-5C25558A11A3Q36941481-3FE6745B-4F25-4698-8435-A92CFEFA5C1DQ36996592-E461FFE6-2E22-4C2F-AF14-8166FFA781F4Q37148519-661AA94C-3869-484B-B2FB-011BE9613DC9Q37153107-A8D6B795-E499-42C6-BE11-5D2861A5E39FQ37232026-3C209607-64DB-493F-9356-F3AA628E92F9Q37256433-41DA06EC-1583-4BA1-81F2-FD91B88EEB19Q37511851-CF320C2E-C0B6-4C37-ABE6-6E768E5ADC50Q37573646-5C4756F0-BB28-4180-AB50-B01EF0282CCEQ37581642-60A619C2-FD8F-4779-9CF1-0520208A399DQ37619231-5FBC4683-BD7C-4DCD-BB3D-E1AD4B714756Q37717441-892E398D-241E-4EA3-BDD7-F9ADABA2BA37Q38042625-28817857-1037-4A59-9460-5D61D46A1F87Q38083725-272D5DA3-635B-49C1-8D0C-FF77DA12239DQ38168763-0DEDCC3E-A1A4-441F-8050-8584371D80DA
P2860
Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Human Pompe disease-induced pl ...... disease marker identification.
@en
Human Pompe disease-induced pl ...... disease marker identification.
@nl
type
label
Human Pompe disease-induced pl ...... disease marker identification.
@en
Human Pompe disease-induced pl ...... disease marker identification.
@nl
prefLabel
Human Pompe disease-induced pl ...... disease marker identification.
@en
Human Pompe disease-induced pl ...... disease marker identification.
@nl
P2093
P2860
P4510
P50
P356
P1476
Human Pompe disease-induced pl ...... disease marker identification.
@en
P2093
Ching-Yu Chuang
Chung-Hsuan Chen
Pin-Hsun Chen
Shu-Chuan Chiang
P2860
P304
P356
10.1093/HMG/DDR424
P50
P577
2011-09-15T00:00:00Z